232 related articles for article (PubMed ID: 23141909)
1. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
[TBL] [Abstract][Full Text] [Related]
2. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
[TBL] [Abstract][Full Text] [Related]
3. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
[TBL] [Abstract][Full Text] [Related]
4. Rapid discovery of triazolobenzylidene-thiazolopyrimidines (TBTP) as CDC25 phosphatase inhibitors by parallel click chemistry and in situ screening.
Duval R; Kolb S; Braud E; Genest D; Garbay C
J Comb Chem; 2009; 11(6):947-50. PubMed ID: 19835352
[No Abstract] [Full Text] [Related]
5. Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases.
Huang W; Li J; Zhang W; Zhou Y; Xie C; Luo Y; Li Y; Wang J; Li J; Lu W
Bioorg Med Chem Lett; 2006 Apr; 16(7):1905-8. PubMed ID: 16434190
[TBL] [Abstract][Full Text] [Related]
6. Effective Pharmacophore for CDC25 Phosphatases Enzyme Inhibitors: Newly Synthesized Bromothiazolopyrimidine Derivatives.
El-Shahat M; Salama MAM; El-Farargy AF; Ali MM; Ahmed DM
Mini Rev Med Chem; 2021; 21(1):118-131. PubMed ID: 32560601
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and molecular modeling studies on novel quinonoid inhibitors of CDC25 phosphatases.
Evain-Bana E; Schiavo L; Bour C; Lanfranchi DA; Berardozzi S; Ghirga F; Bagrel D; Botta B; Hanquet G; Mori M
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):113-118. PubMed ID: 27774816
[TBL] [Abstract][Full Text] [Related]
8. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.
Park H; Bahn YJ; Jung SK; Jeong DG; Lee SH; Seo I; Yoon TS; Kim SJ; Ryu SE
J Med Chem; 2008 Sep; 51(18):5533-41. PubMed ID: 18714978
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.
Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C
Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913
[TBL] [Abstract][Full Text] [Related]
11. Screening of indeno[1,2-b]indoloquinones by MALDI-MS: a new set of potential CDC25 phosphatase inhibitors brought to light.
Alchab F; Sibille E; Ettouati L; Bana E; Bouaziz Z; Mularoni A; Monniot E; Bagrel D; Jose J; Le Borgne M; Chaimbault P
J Enzyme Inhib Med Chem; 2016; 31(sup3):25-32. PubMed ID: 27362889
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J
Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of macrocyclic inhibitors of phosphatase cdc25B.
Bäurle S; Blume T; Günther J; Henschel D; Hillig RC; Husemann M; Mengel A; Parchmann C; Schmid E; Skuballa W
Bioorg Med Chem Lett; 2004 Apr; 14(7):1673-7. PubMed ID: 15026048
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones.
Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J
J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222
[TBL] [Abstract][Full Text] [Related]
15. Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B.
Keinan S; Paquette WD; Skoko JJ; Beratan DN; Yang W; Shinde S; Johnston PA; Lazo JS; Wipf P
Org Biomol Chem; 2008 Sep; 6(18):3256-63. PubMed ID: 18802630
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and functional evaluation of triazine-based bivalent agents that simultaneously target the active site and hot spot of phosphatase Cdc25B.
Nagaoka Y; Parvatkar P; Hirai G; Ohkanda J
Bioorg Med Chem Lett; 2021 Sep; 48():128265. PubMed ID: 34273487
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries.
Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P
Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of caulibugulones A-E.
Wipf P; Joo B; Nguyen T; Lazo JS
Org Biomol Chem; 2004 Aug; 2(15):2173-4. PubMed ID: 15280951
[TBL] [Abstract][Full Text] [Related]
19. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
Park H; Bahn YJ; Ryu SE
Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
[TBL] [Abstract][Full Text] [Related]
20. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
Park H; Li M; Choi J; Cho H; Ham SW
Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
